351 related articles for article (PubMed ID: 18023027)
1. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.
Melum E; Karlsen TH; Schrumpf E; Bergquist A; Thorsby E; Boberg KM; Lie BA
Hepatology; 2008 Jan; 47(1):90-6. PubMed ID: 18023027
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the genetic susceptibility for cholangiocarcinoma in primary sclerosing cholangitis.
Lazaridis KN
Hepatology; 2008 Jan; 47(1):8-10. PubMed ID: 18161699
[No Abstract] [Full Text] [Related]
3. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
[TBL] [Abstract][Full Text] [Related]
5. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
6. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Jesudian AB; Jacobson IM
Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
[TBL] [Abstract][Full Text] [Related]
7. Investigation of cholangiocarcinoma associated NKG2D polymorphisms in colorectal carcinoma.
Melum E; Buch S; Schafmayer C; Kalthoff H; Tepel J; Schreiber S; Karlsen TH; Hampe J
Int J Cancer; 2008 Jul; 123(1):241-2. PubMed ID: 18398827
[No Abstract] [Full Text] [Related]
8. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
[TBL] [Abstract][Full Text] [Related]
9. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?].
Margalit M; Elinav H; Goldin E; Ilan Y
Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825
[TBL] [Abstract][Full Text] [Related]
10. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles.
Wiencke K; Spurkland A; Schrumpf E; Boberg KM
Hepatology; 2001 Oct; 34(4 Pt 1):625-30. PubMed ID: 11584356
[TBL] [Abstract][Full Text] [Related]
11. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.
Wiencke K; Karlsen TH; Boberg KM; Thorsby E; Schrumpf E; Lie BA; Spurkland A
Tissue Antigens; 2007 Feb; 69(2):161-9. PubMed ID: 17257319
[TBL] [Abstract][Full Text] [Related]
12. Primary sclerosing cholangitis and cholangiocarcinoma.
Lazaridis KN; Gores GJ
Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
[TBL] [Abstract][Full Text] [Related]
13. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
Bergquist A; Broomé U
Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for Cholangiocarcinoma.
Wadsworth CA; Dixon PH; Taylor-Robinson S; Kim JU; Zabron AA; Wong JH; Chapman MH; McKay SC; Spalding DR; Wasan HS; Pereira SP; Thomas HC; Whittaker JC; Williamson C; Khan SA
J Clin Exp Hepatol; 2019; 9(2):171-175. PubMed ID: 31024198
[TBL] [Abstract][Full Text] [Related]
15. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Olsson M; Sun JY; Senitzer D; Bergquist A; Schrumpf E; Thorsby E; Lie BA
J Hepatol; 2007 May; 46(5):899-906. PubMed ID: 17383044
[TBL] [Abstract][Full Text] [Related]
16. Association of MICA Gene Polymorphism in Opisthorchis viverrini-Induced Periductal Fibrosis in Northeastern Thais.
Myo Oo TZ; Saichua P; Phoksawat W; Sithithaworn P; Mairiang E; Sripa B; Leelayuwat C; Jumnaisong A
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3213-3219. PubMed ID: 37774074
[TBL] [Abstract][Full Text] [Related]
17. Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinoma.
Chaiteerakij R; Juran BD; Aboelsoud MM; Harmsen WS; Moser CD; Giama NH; Allotey LK; Mettler TA; Baichoo E; Zhang X; Therneau TM; Lazaridis KN; Roberts LR
Cancer Med; 2015 Oct; 4(10):1599-602. PubMed ID: 26276523
[TBL] [Abstract][Full Text] [Related]
18. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Wannhoff A; Hov JR; Folseraas T; Rupp C; Friedrich K; Anmarkrud JA; Weiss KH; Sauer P; Schirmacher P; Boberg KM; Stremmel W; Karlsen TH; Gotthardt DN
J Hepatol; 2013 Dec; 59(6):1278-84. PubMed ID: 23958938
[TBL] [Abstract][Full Text] [Related]
19. Management of primary sclerosing cholangitis.
Björnsson E
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):163-72. PubMed ID: 19305376
[TBL] [Abstract][Full Text] [Related]
20. MYH rs3219476 and rs3219472 polymorphisms and risk of cholangiocarcinoma.
You SH; Wang X; Huang S; Wang M; Ji GZ; Xia JR; Fan ZN
Mol Med Rep; 2013 Jan; 7(1):347-51. PubMed ID: 23138270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
